FR2625099B1 - PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS - Google Patents

PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS

Info

Publication number
FR2625099B1
FR2625099B1 FR8718180A FR8718180A FR2625099B1 FR 2625099 B1 FR2625099 B1 FR 2625099B1 FR 8718180 A FR8718180 A FR 8718180A FR 8718180 A FR8718180 A FR 8718180A FR 2625099 B1 FR2625099 B1 FR 2625099B1
Authority
FR
France
Prior art keywords
poxviruses
toxoplasmosis
antibodies
proteins
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8718180A
Other languages
French (fr)
Other versions
FR2625099A1 (en
Inventor
Guy Bruno
Marie-France Cesbron
Jean-Pierre Lecocq
Andre Capron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Priority to FR8718180A priority Critical patent/FR2625099B1/en
Priority to EP89900842A priority patent/EP0346430A1/en
Priority to JP1500776A priority patent/JPH02502878A/en
Priority to PCT/FR1988/000640 priority patent/WO1989005658A1/en
Publication of FR2625099A1 publication Critical patent/FR2625099A1/en
Application granted granted Critical
Publication of FR2625099B1 publication Critical patent/FR2625099B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8718180A 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS Expired - Fee Related FR2625099B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR8718180A FR2625099B1 (en) 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS
EP89900842A EP0346430A1 (en) 1987-12-24 1988-12-23 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis
JP1500776A JPH02502878A (en) 1987-12-24 1988-12-23 Proteins and their production methods, DNA sequences, antibodies and their applications, poxviruses, transformed or infected cells and pharmaceutical formulations useful for the prevention of toxoplasmosis.
PCT/FR1988/000640 WO1989005658A1 (en) 1987-12-24 1988-12-23 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8718180A FR2625099B1 (en) 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS

Publications (2)

Publication Number Publication Date
FR2625099A1 FR2625099A1 (en) 1989-06-30
FR2625099B1 true FR2625099B1 (en) 1991-06-14

Family

ID=9358323

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8718180A Expired - Fee Related FR2625099B1 (en) 1987-12-24 1987-12-24 PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS

Country Status (4)

Country Link
EP (1) EP0346430A1 (en)
JP (1) JPH02502878A (en)
FR (1) FR2625099B1 (en)
WO (1) WO1989005658A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (en) 1989-12-08 1991-06-13 Behringwerke Ag TOXOPLASMA GONDII-ANTIGENE, THEIR PRODUCTION AND USE
JPH02261382A (en) * 1989-04-03 1990-10-24 Mochida Pharmaceut Co Ltd Novel dna sequence originated from toxoplasma and protein coded therewith
WO1992002624A1 (en) * 1990-08-10 1992-02-20 The Flinders University Of South Australia Cloning and expression of toxoplasma antigens and use of recombinant antigens
FR2714074B1 (en) * 1993-12-20 1996-03-01 Pasteur Institut Promoters of the GRA1, GRA2, GRA5 and GRA6 genes of toxoplasma gondii and expression vectors comprising said promoters.
ZA958366B (en) * 1994-10-06 1996-04-24 Akzo Nobel Nv New toxoplasma gondii antigens
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
DK1856159T3 (en) 2005-03-08 2010-07-05 Sigma Tau Ind Farmaceuti Chimeric recombinant antigens of Toxoplasma gondii
CN103517714A (en) * 2010-12-23 2014-01-15 英珀特疗法有限公司 Methods and compositions of protein antigens for the diagnosis and treatment of toxoplasma gondii infections and toxoplasmosis
WO2014016301A1 (en) * 2012-07-23 2014-01-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) A protein microarray for characterizing the specificity of the monoclonal immunoglobulins of mgus or myeloma patients
FR2994482B1 (en) * 2012-08-13 2014-08-22 Repropharm COMPOSITION, METHOD AND KIT FOR DETECTION OF PREVULATORY PIC OF LH

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2518407A1 (en) * 1981-12-17 1983-06-24 Merieux Inst NOVEL ANTIGEN FOR THE RESEARCH OF TOXOPLASMIC IMMUNITY AND ITS PREPARATION METHOD
US4564592A (en) * 1983-01-21 1986-01-14 Research Corporation Toxoplasmosis factor and production of same
FR2564731B1 (en) * 1984-05-28 1986-10-10 Ambroise Thomas Pierre NOVEL TOXOPLASMIC EXO-ANTIGENIC FRACTIONS, THEIR PREPARATION PROCESS AND THEIR APPLICATION TO THE RESEARCH OF TOXOPLASMIC IMMUNITY IN MAN BY SKIN TESTS
AU613583B2 (en) * 1986-08-22 1991-08-08 Transgene S.A. Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity

Also Published As

Publication number Publication date
FR2625099A1 (en) 1989-06-30
JPH02502878A (en) 1990-09-13
WO1989005658A1 (en) 1989-06-29
EP0346430A1 (en) 1989-12-20

Similar Documents

Publication Publication Date Title
BE880201A (en) PURIFIED PROTEINS, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2722984B1 (en) PROCESS FOR THE PREPARATION OF DRY PHARMACEUTICAL FORMS AND THE PHARMACEUTICAL COMPOSITIONS THUS PRODUCED
PT82575A (en) PROCESS FOR THE PREPARATION OF A CONJUGATE PRODUCT CONSISTING OF AN S.MUTANS ADHESIN OF A PROTEIN NATURE OF A COMPOSITION WITH IMMUNOGEN ACTIVITY AND AN S.MUTANS POLYSACCHARIDE AND USE THEREOF PARTICULARLY IN ANTI-CARIES VACCINES
IT1240605B (en) SOLID PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
AU597698B2 (en) Expression products of human papilloma virus type 18, antibodies specific to these proteins, and diagnostic aids containing these antibodies or corresponding DNA
FR2625099B1 (en) PROTEINS AND THEIR PREPARATION METHOD, DNA SEQUENCES, ANTIBODIES AND THEIR APPLICATION, POXVIRUSES, TRANSFORMED OR INFECTED CELLS AND PHARMACEUTICAL COMPOSITIONS USEFUL IN THE PREVENTION OF TOXOPLASMOSIS
IT8922164A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
FR2598420B1 (en) NOVEL RETINOIC ANTIBIOTICS ESTERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
FR2605004B1 (en) NOVEL AMINO ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
PT84933A (en) PROCESS FOR THE PREPARATION OF CYCLODEPSIPEPTIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2736914B1 (en) NOVEL AMINOPHENYLPHOSPHONIC ACID DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2603040B1 (en) PROTEIN, DNA SEQUENCE, POXVIRUSES, CELLS AND THEIR CULTURE PROCESS, AS WELL AS THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USEFUL IN THE PREVENTION OF SCHISTOSOMOSIS
FR2611497B1 (en) AGGLOMERATES, THEIR PREPARATION AND PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS CONTAINING THEM
FR2582835B1 (en) QUINOLEIN DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1216141B (en) COSMETIC COMPOSITION REGENERATING THE SKIN AND PROCEDURE FOR ITS PREPARATION.
FR2631829B1 (en) FUNGAL EXOPOLYSACCHARIDES HAVING IMMUNOSTIMULANT ACTIVITY, PROCESS FOR OBTAINING SAME AND THERAPEUTIC COMPOSITION CONTAINING THEM
FR2566772B1 (en) DIACYLOXY-1,8 ACYL-10 ANTHRONES, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS
FR2595703B1 (en) NOVEL PHOSPHOLIPIDS, THEIR PROCESS AND PREPARATIONS THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2619008B1 (en) USE OF SYNERGISTINS IN ANTI-ACNEIC PHARMACEUTICAL OR COSMETIC COMPOSITIONS
FR2758560B1 (en) NEW DERIVATIVES OF AMINOPHENYLBORONIC ACIDS, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2588558B1 (en) NOVEL MAMMALIAN PROTEIN, ESPECIALLY HAVING IMMUNOMODULATORY AND PROGESTIVE ACTIVITY, CORRESPONDING ANTIBODIES, THEIR PREPARATION AND THEIR APPLICATION
BE1003232A3 (en) SEQUENTIAL POLYPEPTIDES HAVING IMMUNOLOGICAL ACTIVITY, PROCESS FOR THEIR PREPARATION, AND THEIR USE.
IT1217789B (en) PHARMACEUTICAL COMPOSITION CUE ACCUMULATES IN THE SKIN AND PROCEDURE FOR ITS PREPARATION
FR2617481B1 (en) NOVEL TETRAHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2650824B1 (en) BI-AROMATIC THIOESTERS, THEIR PREPARATION PROCESS AND THEIR USE IN HUMAN OR VETERINARY MEDICINE AND IN COSMETICS

Legal Events

Date Code Title Description
ST Notification of lapse